Sequencing data for ICGC Oesophageal Adenocarcinoma tissue samples - ds_190916_2
ICGC Oesophageal Adenocarcinoma tissue samples
- 20/09/2016
- DAC: EGAC00001000010
- Technology: Illumina HiSeq 2000
- HMB DUO:0000006 (version: 2021-02-23)health or medical or biomedical researchThis data use permission indicates that use is allowed for health/medical/biomedical purposes; does not include the study of population origins or ancestry.
- NPUNCU DUO:0000018 (version: 2021-02-23)not for profit, non commercial use onlyThis data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.
- PS DUO:0000027 (version: 2021-02-23)project specific restrictionThis data use modifier indicates that use is limited to use within an approved project.
- GRU DUO:0000042 (version: 2021-02-23)general research useThis data use permission indicates that use is allowed for general research use for any research purpose.
ICGC Data Access
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001000723 | Other | |
| EGAS00001000724 | Other | |
| EGAS00001000725 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Located in | |
|---|---|---|---|---|
| EGAF00000661620 | bam | 124.6 GB | ||
| EGAF00000661646 | bam | 92.1 GB | ||
| EGAF00000814045 | bam | 114.7 GB | ||
| EGAF00000814055 | bam | 106.6 GB | ||
| EGAF00000814094 | bam | 57.9 GB | ||
| EGAF00000814107 | bam | 54.0 GB | ||
| EGAF00000814108 | bam | 55.5 GB | ||
| EGAF00000814111 | bam | 69.1 GB | ||
| EGAF00000814148 | bam | 104.9 GB | ||
| EGAF00000814153 | bam | 127.6 GB | ||
| 10 Files (907.0 GB) | ||||